ArticleEmergency radiology2026
The prognostic role of pulmonary artery thrombus density among patients with intermediate-risk pulmonary embolism.
Article in Emergency radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. Current risk stratification tools have limitations in predicting short-term outcomes. Radiological parameters such as thrombus density, measured in Hounsfield Units (HU) on computed tomography pulmonary angiography (CTPA), may provide additional prognostic information.
objectiveThis study aims to assess the association between pulmonary artery thrombus density on CTPA and 30-day mortality in patients with intermediate-risk PE.
methodsThis retrospective cohort study included patients diagnosed with acute PE by contrast-enhanced CTPA in the emergency department of a single tertiary center between January 1, 2022, and December 31, 2024. Only patients classified as intermediate-risk according to European Society of Cardiology guidelines were included. HU values were measured from predefined pulmonary artery locations. The primary outcome was 30-day all-cause mortality. Multivariate logistic regression and receiver operating characteristic (ROC) analyses were performed to identify independent predictors and assess discriminative ability.
resultsA total of 121 patients (mean age: 70 ± 14.5 years; 58.5% male) were analyzed. The 30-day mortality rate was 26.4%. Thrombus HU values were significantly higher in deceased patients compared to survivors (median 76 vs. 56, p = 0.001). In multivariate analysis, HU value (OR: 1.03; 95% CI: 1.001-1.06; p = 0.04) and sPESI score (OR: 1.70; 95% CI: 1.04-2.78; p = 0.03) were independent predictors. AUCs were 0.702 for HU and 0.731 for sPESI.
conclusionsThrombus density on CTPA was independently associated with 30-day mortality in intermediate-risk PE. HU measurement may serve as a practical imaging biomarker for early prognostic assessment.
Indexed as
Identifiers
41398491What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.